2007 Safety and Availability Communications
This webpage was developed to provide the public with important information about the safety and availability of biological products.
- Interim Recommendations for the Use of Haemophilus influenzae Type b (Hib) Conjugate Vaccines Related to the Recall of Certain Lots of Hib-Containing Vaccines (PedvaxHIB® and Comvax®)
MedWatch Safety Alerts for Human Medical Products FDA Statement on Gene Therapy Clinical Trial[ARCHIVED] Potential Risk of Variant Creutzfeldt-Jakob Disease (vCJD) From Plasma-Derived Products[ARCHIVED] FDA Public Health Notification: Unpredictable Events in Medical Equipment due to New Daylight Saving Time Change[ARCHIVED] Advice for Patients: Change in Daylight Saving Time May Affect Your Medical Equipment in an Unpredictable Way[ARCHIVED] FDA Public Health Notification: Information on RotaTeq and Intussusception[ARCHIVED]
- Postmarketing Monitoring of Intussusception After RotaTeq™ Vaccination --- United States, February 1, 2006--February 15, 2007